Amakem, Flemish Agency for Innovation by Science and Technology autoimmune news

Amakem received an €1.4 million ($1.8 million) grant from the agency to use Amakem's localized drug action technology to discover and develop kinase inhibitor-based therapies to treat inflammatory bow...